FDA holds meeting on Pfizer booster shot

Health experts are divided as the FDA panel convenes to review Pfizer's recommendation that people 16 and over receive a third shot of the vaccine.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting